About Index Trending news
Analyze
Top 50 Pricing
Avaxia Biologics

Avaxia Biologics

Work at Avaxia Biologics? Add yourself to this profile

Avaxia Biologics

Avaxia Biologics develops orally-delivered antibody therapeutics using a proprietary antibody platform.

Elsewhere

Alexa global traffic share

01 Dec 2014
Convertible Note
06 May 2014
$3,096,371
Debt financing
01 Apr 2014
Convertible Note
20 Dec 2013
$2,872,388
Debt financing
07 Jun 2013
$11,500,000
Venture capital (Series B)
01 Jul 2012
Seed fund
01 Jun 2012
Convertible Note
14 Feb 2012
$4,100,000
Venture capital (Series A)
01 Jun 2011
Convertible Note